CIK 0001622229 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2021 | |
|---|---|---|---|---|
| Net income (USD) | -72.3 M | -74.8 M | ||
| Diluted EPS (USD/shares) | -2.16 | -1.73 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | 4 | 4 | 2026-10-01 |
| 2026-09-02 | 8-K | 8-K items 1.01 | 2026-09-01 |
| 2026-08-31 | 4 | 4 | 2026-08-27 |
| 2026-08-27 | 144 | 144 | |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-10 | 8-K | 8-K items 8.01,9.01 | 2026-08-10 |
| 2026-08-10 | 424B5 | 424B5 | |
| 2026-08-10 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-10 | 8-K | 8-K items 2.02,9.01 | 2026-08-10 |
| 2026-07-31 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-27 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-06 | 4 | 4 | 2026-07-01 |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-06-11 | 4 | 4 | 2026-06-09 |
| 2026-06-11 | 8-K | 8-K items 5.07 | 2026-06-09 |
| 2026-05-21 | 4 | 4 | 2026-05-19 |
| 2026-05-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-05 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-05 | 8-K | 8-K items 2.02,9.01 | 2026-05-05 |
| 2026-04-23 | ARS | ARS | 2025-12-31 |
| 2026-04-23 | DEFA14A | DEFA14A |
Forms on file (last 1,000): 4 216, 8-K 98, SC 13G/A 42, 3 28, SC 13G 28, 10-Q 26, SCHEDULE 13G/A 21, 424B5 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=COGT (0.002 USD), /gw/filings/filings?ticker=COGT&form=8-K, /gw/filings/facts?ticker=COGT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange